Golan, H.; Mechoulam, R.; Smoum, R.; Cohen-Zada, E.; Pri-Chen, S.; Wiener, S.; Grinberg, I.; Bar-Lev, D.D.; Haj, C.G.; Fisher, T.;
et al. Anti-Tumorigenic Effect of a Novel Derivative of 2-Hydroxyoleic Acid and the Endocannabinoid Anandamide on Neuroblastoma Cells. Biomedicines 2022, 10, 1552.
https://doi.org/10.3390/biomedicines10071552
AMA Style
Golan H, Mechoulam R, Smoum R, Cohen-Zada E, Pri-Chen S, Wiener S, Grinberg I, Bar-Lev DD, Haj CG, Fisher T,
et al. Anti-Tumorigenic Effect of a Novel Derivative of 2-Hydroxyoleic Acid and the Endocannabinoid Anandamide on Neuroblastoma Cells. Biomedicines. 2022; 10(7):1552.
https://doi.org/10.3390/biomedicines10071552
Chicago/Turabian Style
Golan, Hana, Raphael Mechoulam, Reem Smoum, Efrat Cohen-Zada, Sara Pri-Chen, Sapir Wiener, Igor Grinberg, Dekel D. Bar-Lev, Christeeneh G. Haj, Tamar Fisher,
and et al. 2022. "Anti-Tumorigenic Effect of a Novel Derivative of 2-Hydroxyoleic Acid and the Endocannabinoid Anandamide on Neuroblastoma Cells" Biomedicines 10, no. 7: 1552.
https://doi.org/10.3390/biomedicines10071552
APA Style
Golan, H., Mechoulam, R., Smoum, R., Cohen-Zada, E., Pri-Chen, S., Wiener, S., Grinberg, I., Bar-Lev, D. D., Haj, C. G., Fisher, T., & Toren, A.
(2022). Anti-Tumorigenic Effect of a Novel Derivative of 2-Hydroxyoleic Acid and the Endocannabinoid Anandamide on Neuroblastoma Cells. Biomedicines, 10(7), 1552.
https://doi.org/10.3390/biomedicines10071552